Description: Hypoxia contributes significantly to the pathophysiology of major categories of human disease, including myocardial and cerebral ischemia, cancer, pulmonary hypertension, congenital heart disease and chronic obstructive pulmonary disease. HIF-2 alpha is predominantly expressed in highly vascularized tissues of adult humans and endothelial cells of the embryonic and adult mouse, whereas HIF-1alpha functions primarily in extravascular tissues. HIF-2 alpha is also a potent activator of the tie-2 gene, which is known to be selectively expressed in endothelial cells.
Primary Antibody
|
Name: HIF-2-alpha Antibody |
|
Clone: Rabbit polyclonal |
|
Supplier: Novus Biologicals |
|
Catalog Number: NB100-122 |
|
Dilution: 1:300 - 1:500 using IHC-TekTM Antibody Diluent (Cat# IW-1000 or IW-1001) to reduce background and unspecific staining and serum blocking step is NOT needed. |
|
Incubation Time/Temp: 60 minutes/room temperature |
| Device: IHC-TekTM Epitope Retrieval Steamer Set (Cat# IW-1102) |
| Buffer/pH value: IHC-TekTM Epitope Retrieval Solution (Cat# IW-1100) |
| Heat/Cool Temperature: 95 ºC - 100 ºC/room temperature |
| Heat/Cool Time: 20 minutes/20 minutes |
| Standard Method: ABC Method or LSAB Method |
| Enhanced Method: Polymeric Methods |
| Reagent: DAB |
| Incubation Time/Temperature: 1-3 minutes/room temperature |
| Reagent: Gill's Hematoxylin or Mayer's Hematoxylin |
| Staining Time: 30 seconds |
| Staining Pattern: Nuclear/cytoplasmic |
| Images: Search image |
|
Species Reactivity: Mouse, rat, human |
|
Fixation: Formalin fixed paraffin sections |
|
Positive Control: Mouse skin |
|
Negative Control: Omit primary antibody, isotype control or absorption control |
|
Blocking: 2-5% normal serum to reduce unspecific background staining; 0.5-3% H2O2 to block endogenous peroxidase activity; avidin/biotin to block endogenous biotin activity if necessary |
Not tested on frozen sections. |
References: